Alan M. Solinger

2.7k total citations
36 papers, 1.8k citations indexed

About

Alan M. Solinger is a scholar working on Immunology, Rheumatology and Epidemiology. According to data from OpenAlex, Alan M. Solinger has authored 36 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 13 papers in Rheumatology and 10 papers in Epidemiology. Recurrent topics in Alan M. Solinger's work include Autoimmune and Inflammatory Disorders Research (6 papers), Systemic Lupus Erythematosus Research (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Alan M. Solinger is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (6 papers), Systemic Lupus Erythematosus Research (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Alan M. Solinger collaborates with scholars based in United States, Denmark and Germany. Alan M. Solinger's co-authors include Charles A. Dinarello, Suzanne L. Bowyer, Daniel J. Lovell, Paul Scholl, Sudha Visvanathan, Steven J. Padula, Stella Aslanyan, John D. Stobo, Marcus R. Clark and Marc C. Hochberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Alan M. Solinger

36 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan M. Solinger United States 21 780 639 392 349 309 36 1.8k
Anne Nicholls United Kingdom 10 1.2k 1.6× 1.7k 2.7× 544 1.4× 513 1.5× 215 0.7× 15 2.9k
Kazuhiro Kurasawa Japan 26 1.1k 1.5× 692 1.1× 324 0.8× 359 1.0× 604 2.0× 81 2.4k
David Senitzer United States 28 1.1k 1.4× 293 0.5× 647 1.7× 254 0.7× 433 1.4× 115 2.3k
Pierre‐Yves Berclaz United States 18 633 0.8× 378 0.6× 187 0.5× 243 0.7× 167 0.5× 30 1.6k
Naoto Tamura Japan 23 884 1.1× 1.0k 1.6× 219 0.6× 327 0.9× 326 1.1× 196 2.2k
Evelyne T. Edwards United States 5 606 0.8× 885 1.4× 400 1.0× 91 0.3× 389 1.3× 6 1.9k
Rose Goldstein Canada 27 800 1.0× 707 1.1× 101 0.3× 234 0.7× 539 1.7× 56 1.8k
H Chwalińska-Sadowska Poland 14 992 1.3× 1.3k 2.0× 231 0.6× 187 0.5× 212 0.7× 29 1.9k
C. Darke United Kingdom 24 1.1k 1.4× 466 0.7× 700 1.8× 160 0.5× 167 0.5× 151 2.4k
Yair Molad Israel 25 725 0.9× 959 1.5× 220 0.6× 415 1.2× 178 0.6× 70 2.1k

Countries citing papers authored by Alan M. Solinger

Since Specialization
Citations

This map shows the geographic impact of Alan M. Solinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan M. Solinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan M. Solinger more than expected).

Fields of papers citing papers by Alan M. Solinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan M. Solinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan M. Solinger. The network helps show where Alan M. Solinger may publish in the future.

Co-authorship network of co-authors of Alan M. Solinger

This figure shows the co-authorship network connecting the top 25 collaborators of Alan M. Solinger. A scholar is included among the top collaborators of Alan M. Solinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan M. Solinger. Alan M. Solinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baeten, Dominique, Mikkel Østergaard, James Cheng‐Chung Wei, et al.. (2018). Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study. Annals of the Rheumatic Diseases. 77(9). 1295–1302. 279 indexed citations
2.
Krueger, James G., Laura K. Ferris, Alan Menter, et al.. (2015). Anti–IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial. Journal of Allergy and Clinical Immunology. 136(1). 116–124.e7. 194 indexed citations
3.
Cavelti‐Weder, Claudia, Cornelia Keller, Marc Stahel, et al.. (2012). Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes. Diabetes Care. 35(8). 1654–1662. 229 indexed citations
4.
Gül, Ahmet, İlknur Tuğal-Tutkun, Charles A. Dinarello, et al.. (2011). Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behçet's disease: an open-label pilot study. Annals of the Rheumatic Diseases. 71(4). 563–566. 176 indexed citations
5.
Lovell, Daniel J., Suzanne L. Bowyer, & Alan M. Solinger. (2005). Interleukin‐1 blockade by anakinra improves clinical symptoms in patients with neonatal‐onset multisystem inflammatory disease. Arthritis & Rheumatism. 52(4). 1283–1286. 113 indexed citations
6.
Tesser, John, Roy Fleischmann, Robin K. Dore, et al.. (2004). Concomitant medication use in a large, international, multicenter, placebo controlled trial of anakinra, a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis.. PubMed. 31(4). 649–54. 29 indexed citations
7.
Schiff, Michael, John Tesser, Roy Fleischmann, et al.. (2004). The safety of anakinra in high‐risk patients with active rheumatoid arthritis: Six‐month observations of patients with comorbid conditions. Arthritis & Rheumatism. 50(6). 1752–1760. 66 indexed citations
8.
Solinger, Alan M.. (2003). Rheumatic manifestations of human immunodeficiency virus. Current Rheumatology Reports. 5(3). 205–209. 5 indexed citations
9.
10.
Solinger, Alan M. & E V Hess. (1993). Rheumatic diseases and AIDS--is the association real?. PubMed. 20(4). 678–83. 22 indexed citations
11.
Clark, Marcus R., Alan M. Solinger, & Marc C. Hochberg. (1992). HUMAN IMMUNODEFICIENCY VIRUS INFECTION IS NOT ASSOCIATED WITH REITER’S SYNDROME. Rheumatic Disease Clinics of North America. 18(1). 267–276. 37 indexed citations
12.
Solinger, Alan M. & Evelyn V. Hess. (1991). Induction of Autoantibodies by Human Immunodeficiency Virus Infection and Their Significance. Rheumatic Disease Clinics of North America. 17(1). 157–176. 20 indexed citations
13.
Linnemann, Calvin C., et al.. (1990). Emergence of acyclovir-resistant varicella zoster virus in an AIDS patient on prolonged acyclovir therapy. AIDS. 4(6). 577–580. 85 indexed citations
14.
Solinger, Alan M.. (1988). Drug-Related Lupus. Rheumatic Disease Clinics of North America. 14(1). 187–202. 26 indexed citations
15.
Solinger, Alan M., Louis E. Adams, Alvin E. Friedman‐Kien, & Evelyn V. Hess. (1988). Acquired immune deficiency syndrome (AIDS) and autoimmunity—Mutually exclusive entities?. Journal of Clinical Immunology. 8(1). 32–42. 21 indexed citations
16.
Solinger, Alan M.. (1988). Drug-related lupus. Clinical and etiologic considerations.. PubMed. 14(1). 187–202. 33 indexed citations
17.
Bills, Gerald F., et al.. (1985). Minute foci of Kaposi's sarcoma in a patient with acquired immunodeficiency syndrome.. PubMed. 109(2). 106–7. 5 indexed citations
18.
Baughman, Robert P., Alan M. Solinger, Paul E. Hurtubise, et al.. (1983). BRONCHO ALVEOLAR LAVAGE IN PATIENTS WITH THE ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) 1,2. PubMed. 1(2). 91–97. 2 indexed citations
19.
Solinger, Alan M. & John D. Stobo. (1982). Immune Response Gene Control of T Dependent Reactivity to Collagen in Man. Advances in experimental medicine and biology. 150. 141–155. 1 indexed citations
20.
Solinger, Alan M., Rajendra S. Bhatnagar, & John D. Stobo. (1981). Cellular, molecular, and genetic characteristics of T cell reactivity to collagen in man.. Proceedings of the National Academy of Sciences. 78(6). 3877–3881. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Nicholls Breakdown of academic impact, for papers by Kazuhiro Kurasawa Breakdown of academic impact, for papers by David Senitzer Breakdown of academic impact, for papers by Pierre‐Yves Berclaz Breakdown of academic impact, for papers by Naoto Tamura Breakdown of academic impact, for papers by Evelyne T. Edwards Breakdown of academic impact, for papers by Rose Goldstein Breakdown of academic impact, for papers by H Chwalińska-Sadowska Breakdown of academic impact, for papers by C. Darke Breakdown of academic impact, for papers by Yair Molad
Rankless by CCL
2026